|
⚲
|
| Keyboard |
| Schroeder Theodore R
✚
|
|
|---|---|
| CIK # | 0001378690 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001378690] | |
| 4 | [0001378690] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 1,400 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 875 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 875 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 450 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 550 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 2,125 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 550 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 11,100 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 20,500 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 2,125 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2026-01-07 | Disposed to issuer | 550 | ||
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2025-06-18 | Grant | 11,100 | $0.00 | |
|
Phathom Pharmaceuticals Inc PHAT
Common Stock
|
2025-04-16 | Grant | 21,000 | $0.00 | |
|
Phathom Pharmaceuticals Inc PHAT
Common Stock (Right to Buy) · derivative
|
2025-04-16 | Grant | 35,000 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2024-12-17 | Grant | 20,500 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2024-07-18 | Grant | 2,125 | $0.00 | |
|
K2 Therapeutics Inc CDTX
Stock Option (right to buy) · derivative
|
2023-06-22 | Grant | 42,500 | $0.00 | |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2023-01-29 | Tax withheld | 431 | $1.50 | 646 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2023-01-06 | Tax withheld | 11 | $1.30 | 14 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2022-12-31 | Tax withheld | 5 | $1.89 | 9 |
| showing 20 of 150 most recent transactions | |||||